Company Introduction Marketing Plan OfHCG & HMG
Transcript of Company Introduction Marketing Plan OfHCG & HMG
GroupIntroductio
nBiogenist Pharma (Pvt.) Ltd.
A Company Dedicated to
Women Health
Specially
Infertility
Biogenist Pharma (Pvt) Ltd.
Biogenist Pharma (Pvt.) Ltd.
Biogenist Pharma (Pvt) Ltd.
Biogenist Pharma (Pvt.) Ltd.
Mission
Biogenist Pharma (Pvt) Ltd. is dedicated to serve humanity especially in the segments of women health by bringing innovative and State-of-the-art products to bring happiness and comforts in their life. Initially we were focused on the Segment of Obs & Gyne specially infertility. After setting Benchmarks of services & quality in the segment of Infertility, we will expend its operations and entering new segments of Pakistan Pharmaceutical Market with the aim of providing effective & economical medicines for the entire community
Biogenist P
harma (P
vt.) Ltd.
Vision
By 2012 Biogenist will be known to the Pr Practicing Gynecologists as a company caring the entire basic healthcare needs of a common person.
Biogenist Pharma (Pvt.) Ltd.
Our Working Spectrum All Infertility Centers of Pakistan
• Australian Concept Infertility Medical Center - Karachi• Baqai Institute of Reproductive Sciences (BIRDS) – Karachi• Sind Institute of Reproductive Medicine (SIRM) - Karachi• Islamabad Clinic Serving Infertile Couples (Pvt) Ltd - Islamabad• Infertility Services (Pvt) Ltd - Islamabad • Gynecological Advisory Services - Islamabad • Lahore Institute of Fertility & Endocrinology (LIFE) – Lahore • Liaquat National Hospital (LNH)• Aga Khan University Hospitals• Armed Forces Institution of Pakistan• Practicing Gynecologists
Biogen
ist Ph
arma (P
vt.) Ltd
.
Operating in major cities of Pakistan
• Karachi• Hyderabad• Quetta• Lahore• Multan• Bahawalpur• Faisalabad• Islamabad• Rawalpindi• Abbotabad• Peshawar
Biogenist Pharma (Pvt) Ltd.
Biogenist Pharma (Pvt.) Ltd.
Marketing Plan 2010
HMG & HCG
Biogenist Pharma (Pvt) Ltd.
Executive Summary
With the increase in awareness about infertility and its management, simultaneously there is an increase in the growth of Gonadotropins market in Pakistan. The gynecologist in big cities has all the potential to prescribe expensive products like gonadotropins or progesterone like Cyclogest.
The HMG market is growing day by day as doctors have good experience of using HMG e.g. HMG Massone and IVF-M which are already been marketed by Excel & L.G earlier.
In the first phase Biogenist Pharma will identify those gynecologist who has used it in their practice.
In the second phase we will create an awareness among gynecologist on the role of Highly Pure HMG as ovulation inducer through lectures program and product presentations .
There are 11 IVF & 4 IVC centers in Pakistan how are using HMG
2010
Biogenist Pharma (Pvt) Ltd.
Market Review / Situation analysis
Gonadotropins Market = Rs. 921 million(including FSH, LH, hCG & CC)
Unit Value* Growth
hMH 120000 174.1 173%
hCG 192000 335 7%
rFSH 50000 240 20%
Pure FSH 15000 13.9 -
CC 544,000 158 5%
*Value in Millions 3QRT/2008
2010
Biogenist Pharma (Pvt) Ltd.
IVF Centres of Pakistan
There are Ten IVF Centres in Pakistan
1. Lahore institute of Infertility & Endocrinology –(LIFE)
Lahore
2. Serge Med Infertility Care - Lahore
3. New Australian Concept Medical Centre - Lahore
4. Australian Concept Medical Centre – Karachi
5. Sindh institute of Reproductive Medicine – Karachi
HMG in IVF Centers2010
Biogenist Pharma (Pvt) Ltd.
HMG in IVF Centers Baqai Institute of reproduction and development Sciences
(Birds) Karachi
New Australian Concept Medical Centre – Karachi
Saad Rana’s Infertility Clinic Islamabad
Infertility Services (Pvt) Ltd Islamabad
Islamabad Clinic Serving Infertile Couples (ICSI) Islamabad
Note: New 4 IVF & 3 IVC centres are on the way
2010
Biogenist Pharma (Pvt) Ltd.
Hormonal Injectable Preparations Available In Pakistan Market
Products Company
HMG Massone Excel Healthcare Lab
Gonacor Excel Healthcare Lab
Pregnyl Organon
Purigon Organon
Gonal-F Hilton
IVF-M LG
IVF-C LG
Follimon LG
Menogon Ferring
2010
Biogenist Pharma (Pvt) Ltd.
Price Comparison HMG
Brand Name Company Pack size MRP
Menogon 75 IU Ferring 1 x 1 700
HMG Massone100 IU Massone 1 x 1 573
Humegon 75IU Serono 1 x 1 750(Discontinued)
IVF-M 75 IU LG 1 x 1 500
IVF-M 150 IU LG 1 x 1 900
2010
Biogenist Pharma (Pvt) Ltd.
Price Comparison HCG
Brand Name Company Pack size MRP
Pregnyl 1500 IU Organon 1 x 1 200
Pregnyl 5000 IU Organon 1 x 1 700
Gonacor 5000 IU Massone 1 x 1 573
IVF-C 1000 IU LG 1 x 1 150
IVF-C 5000 IU LG 1 x 1 500
2010
Biogenist Pharma (Pvt) Ltd.
Price Comparison FSH
Brand Name Company Pack size MRP
Puregon 50 IU Organon 1 x 1 1700
Puregon 100 IU Organon 1 x 1 3400
Fertinorm 75IU Serono 1 x 1 1050(Discontinued)
Follimon 75 IU LG 1 x 1 900
Follitrin 75 IU Massone 1 x 1 900
2010
Biogenist Pharma (Pvt) Ltd.
Situation Analysis
At present, there are many national & multinational companies serving the infertility segment. The Gonadotropins market is also showing an increasing growth trend. This is due to the increase in awareness of both doctors as well as the end users (the patients).
According to data of 3ed QTR 2008 the total Gonadotropin market worth Rs. 921 million at a healthy growth rate of 16%.
Keeping in view the increasing growth trend in the hormone market one can predict that there will be more business opportunities in future provided the services & introduction of new researched products.
As far as HMG & HCG market is concerned, the market share is divided in to two players Massone by excel & LG market by Galaxy .
2010
Biogenist Pharma (Pvt) Ltd.
Market Segmentation:
Biogenist Pharma (Pvt) Ltd will place HMG in the segment of infertility with a special reference HMG provides best quality of FSH & with LH form Highly pure Europeans source
Segmentation Strategy:
Biogenist Pharma (Pvt) Ltd will provide solution to practicing gynecologist who has problems in dealing with oral medicine during infertility management.
2010
Biogenist Pharma (Pvt) Ltd.
Target Market:
PCO is one of the most common endocrine disorders among women during their reproductive age.
According to the survey conducted by Biogenist Pharma (Pvt) Ltd team, the incidence rate of infertility due to PCO is about 40% to 50% and thus MHG & HCG can be placed as a drug of choice.
Target Marketing Strategy:
As infertility is a niche segment we will adopt a concentrated marketing strategy according to…
• Company resources availability
• The degree of product acceptance
• Product life Cycle stage
• Competitor’s marketing strategy
2010
Biogenist Pharma (Pvt) Ltd.
Market Positioning Statement
“HMG provides best quality of FSH & with LH for your Clomiphene Resistant patient where you need safe and effective therapy at economical price .”
2010
IndicationIndication• Ovulation Induction in Ovulatory Patients Ovulation Induction in Ovulatory Patients • Anovulatory Cycles Anovulatory Cycles • Recurrent Miscarriage of Endocrine OriginRecurrent Miscarriage of Endocrine Origin• Male InfertilityMale Infertility• Assisted Fertilization in IVF CentersAssisted Fertilization in IVF Centers
HMG The mainstay in Ovulation Induction•HMG Confirms the growth & recruitment process of HMG Confirms the growth & recruitment process of
folliculogenesis.folliculogenesis.
•HMG Regulates the aromatization process through LH.HMG Regulates the aromatization process through LH.
•HMG Ensures a competent oocyte & improve fertilization HMG Ensures a competent oocyte & improve fertilization
rate. rate.
HMG Significantly reduces miscarriage rates.HMG Significantly reduces miscarriage rates.
SWOT ANALYSIS
Strengths
• Good penetration in the segment of Gyne / Obs & IVF
Centers
• A product from Highly pure Europeans source in
field of gonadotropins.
• Strong Distribution network, Presence in major cities of
Pakistan
• Trained field force.
Weakness
• HMG & HCG is Urinary Gonadotropin while rFSH is more
popular among IVF & IVC gynecologists
•Poor socioeconomic condition. ( High Price)
• Less Awareness among General gynecologists about
Gonadotropin
2010
Biogenist Pharma (Pvt) Ltd.
SWOT ANALYSIS (Cont…)
Opportunities
•Growing Market & acceptance for new research
products. • Increasing awareness among the patients for the
treatment of
infertility.• Less focus of competitor in street business.• Biogenist Pharma (Pvt) Ltd image as a company
dedicated to women health. • More IVF Centers are expected to be functional in
the near
future.
Threats
• Strong competition from Multinational & National
like Organon and Branded Generic Companies in
IVF Centers.• Government Policies against imported products.• Threat of mergers and collaboration at level of
principal.
2010
HMG & HCG Objective:
To establish HMG & HCG as drug of choice in cases of infertility management among practicing gynecologist.
Qualitative:
To create awareness among gynecologist about the safe and effective use of HMG & HCG in the cases of ovulation induction
Quantitative (Forecast):
Product Year 1 Year 2 Year 3
HMG 75 IU 24000 3600048000
HCG 5000 IU 60000 120000180000
FSH 75 IU 5000 7000 10000 Marketing Strategy• To identify those gynecologists who are already aware of using pure FSH
• To identify and convince practicing gynecologist about the use of HMG & HCG through awareness programs
2010
Tactical Plan
Pre launch Activities
• Doctor List• Teaser and Introductory letter to doctors / Pharmacies• Development of training / promotional material• Availability at retail shop level ( Selected)
Awareness Programs
• Launching conference: Karachi• Speaker: Dr. Shaheen Zafar• Participants A Class IVF Gynecologists
• Launching Conference Lahore• Speaker: Dr. Saqib Siddiiq• Audience: IVF Gynecologist
•Launching conference: Rawalpindi /Islamabad•Speaker: Dr. Saad Rana / Dr. Naseem Ashraf•Participants A Class IVF Gynecologists
2010
Biogenist Pharma (Pvt) Ltd.
Tactical Plan (Cont…)
Awareness Programs (Cont…)
• Launching Conference Peshawar• Speaker: Dr. Naseem Ashraf• Audience: A Class Gynecologist
• Launching Conference Quetta • Speaker: Dr. Shaheen Zafar• Audience: A Class Gynecologist
Other Post Launch Activities:
• RTM’s• Product presentation• Symposia / Seminar • Participation in Annual Conference• Ward Program
Training of Field Force. (Product and Skills)
• Launching conference on Regional level
2006
Biogenist Pharma (Pvt) Ltd.
2010
Promotional Plan
Objective:
• To establish HMG & HCG as a product of choice among those gynecologist who have awareness about the use of Clomiphene .
• To identify & convince practicing gynecologist who are using other treatments for infertility through awareness programs
• To generate sales of HMG in IVF - Centers
Strategies
Phase IIn all the regions and districts field force will provide a list of Customers who are treating infertility or willing to use & keep their promotional focus to listed doctors.
Phase IIThe field force will identify future potential customers and HMG & HCG promotion will start through a round table meeting / local speaker program.
Biogenist Pharma (Pvt) Ltd.
2010 Drug Manual and Training Content
1. Reproductive System
2. Hypothalamic Pituitary Ovarian Axis
3. The Biosynthetic Pathway for Estrogen
4. Two Cell Two Hormone Theory
5. Disease Concept
6. Ovarian Stimulation Protocol with Follitrin in PCO
7. Product Profile
•Polycystic Ovarian Disease
•Hyperinsulinemia
•Obesity
•Hirsutism
•Infertility
Biogenist Pharma (Pvt) Ltd.
2010
HCG Launch Schedule
Launching / Training Conference
Pre-Launch Activities:
• Training / Product Manual
• Reprints & Studies
• Literature Printing
• Doctor’s List accomplishment
• Visit & Discussion with IVF doctors to understand the role and usage of HMG, HCG & FSH
Biogenist Pharma (Pvt) Ltd.
2010
Biogenist Pharma (Pvt) Ltd.